Search Results - "Cathcart, K S"
-
1
Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients
Published in Drug metabolism and disposition (01-04-2000)“…This study determined the disposition of irinotecan hydrochloride trihydrate (CPT-11) after i.v. infusion of 125 mg/m 2 (100 μCi) [ 14 C]CPT-11 in eight…”
Get full text
Journal Article -
2
Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: I. Single-dose administration
Published in Journal of clinical pharmacology (01-02-1993)“…The single-dose tolerability and pharmacokinetics of tirilazad mesylate, a 21-aminosteroid free radical scavenger, were assessed in 47 healthy male subjects…”
Get more information
Journal Article -
3
Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: II. Multiple-dose administration
Published in Journal of clinical pharmacology (01-02-1993)“…The multiple dose tolerability and pharmacokinetics of tirilazad mesylate, a 21-aminosteroid free radical scavenger, were assessed in 50 healthy male…”
Get more information
Journal Article -
4
Pharmacokinetics of intravenously administered cefmetazole and cefoxitin and effects of probenecid on cefmetazole elimination
Published in Antimicrobial Agents and Chemotherapy (01-03-1989)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
5
Disposition of cefmetazole in healthy volunteers and patients with impaired renal function
Published in Antimicrobial Agents and Chemotherapy (01-04-1990)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
6
Pharmacokinetic and tolerance studies of cefpodoxime after single- and multiple-dose oral administration of cefpodoxime proxetil
Published in Journal of clinical pharmacology (01-12-1991)“…Cefpodoxime proxetil, a third generation, broad-spectrum, oral cephalosporin, was administered in single doses of 100, 200, 400, 600, and 800 mg (dose…”
Get more information
Journal Article -
7
An on-line, column-switching high-performance liquid chromatographic procedure for the removal of probenecid from human plasma, serum, or urine in the quantitative determination of cefmetazole or cefoxitin
Published in Journal of pharmaceutical and biomedical analysis (1989)Get more information
Journal Article -
8
Effect of culture-medium temperature on growth of Neisseria gonorrhoeae
Published in The Journal of the American Osteopathic Association (01-08-1990)“…This study was designed to evaluate the effects of culture-medium temperatures on the growth of known quantities of in vitro inoculum of Neisseria gonorrhoeae…”
Get more information
Journal Article -
9
Preclinical studies and clinical correlation of the effect of alkylating dose
Published in Cancer research (Chicago, Ill.) (15-11-1988)“…Dose-response studies were performed with the alkylating agents [nitrogen mustard, N,N'-bis(2-chloroethyl)-N-nitrosourea, melphalan, cisplatin (CDDP),…”
Get full text
Journal Article -
10
Disposition of cefmatazole in healthy volunteers and patients with impaired renal function
Published in Antimicrobial agents and chemotherapy (1990)Get full text
Journal Article -
11
Combination of N,N',N″-triethylenethiophosphoramide and cyclophosphamide in vitro and in vivo
Published in Cancer research (Chicago, Ill.) (1988)“…In vitro and in vivo studies with the drug combination thioTEPA and cyclophosphamide (CPA) were carried out using the MCF-7 human breast carcinoma cell line…”
Get full text
Journal Article -
12
Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine model
Published in The Journal of clinical investigation (01-05-1987)“…DNA-DNA crosslinks are the lethal cellular mechanism of bifunctional alkylating agent cytotoxicity. Novobiocin, an inhibitor of DNA topoisomerase II, impairs…”
Get full text
Journal Article -
13
Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents
Published in Cancer research (Chicago, Ill.) (01-02-1989)“…Our previous in vitro studies demonstrated marked synergy with alkylating agents when novobiocin was present during and after alkylating agent exposure. To…”
Get full text
Journal Article -
14
Effects of various oxygenation conditions on the enhancement by fluosol-DA melphalan antitumor activity
Published in Cancer research (Chicago, Ill.) (01-10-1987)“…The cytotoxicity of melphalan toward exponentially growing FSaIIC fibrosarcoma cells under hypoxia, normal aeration, hyperoxygenation, and stationary phase…”
Get full text
Journal Article -
15
Efficacy of Pt(Rh-123)2 as a radiosensitizer with fractionated X rays
Published in International journal of radiation oncology, biology, physics (01-08-1987)“…The complex of tetrachloroplatinate and rhodamine-123, Pt(Rh-123)2 has demonstrated cytotoxic and antitumor effects and radiosensitizing potential in vitro and…”
Get more information
Journal Article -
16
Ability of four potential topoisomerase II inhibitors to enhance the cytotoxicity of cis-diamminedichloroplatinum (II) in Chinese hamster ovary cells and in an epipodophyllotoxin-resistant subline
Published in Cancer chemotherapy and pharmacology (1990)“…Four drugs known to interact with topoisomerase II were assessed for their ability to enhance the cytotoxicity of cis-diamminedichloroplatinum(II) (CDDP) in…”
Get full text
Journal Article -
17
-
18
The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo
Published in Cancer chemotherapy and pharmacology (01-06-1988)“…The addition of Fluosol-DA followed by carbogen breathing increased the antitumor effect of cyclophosphamide as measured by both tumor growth delay and tumor…”
Get full text
Journal Article -
19
Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity
Published in Cancer chemotherapy and pharmacology (01-01-1988)“…The tumor growth delay produced by the combination of etoposide with the alkylating agent CDDP or BCNU and Fluosol-DA with carbogen breathing in three model…”
Get full text
Journal Article -
20
Some Complexes of Cobalt(III) and Iron(III) Are Radiosensitizers of Hypoxic EMT6 Cells
Published in Radiation research (01-01-1987)“…The radiosensitizing potential in hypoxic EMT6 cells of several complexes of Co(III) and Fe(III) has been examined. The cytotoxicity of each of the agents…”
Get full text
Journal Article